[A case of small cell lung carcinoma associated with pneumoconiosis who responded well to the over twenty chemotherapy treatments, resulting in prolonged survival].
In a 62-year-old man with pneumoconiosis (management 4), small cell lung carcinoma (intermediate cell type) was detected at the routine health examination for pneumoconiosis. The stage of the disease was III B (T2N3M0). Chemotherapy was undertaken over twenty times, resulting in a prolonged survival time (42.5 months). A case of this kind with small cell lung cancer responding well to repeated chemotherapy (decreased tumor size and tumor marker) until the terminal stage seems relatively rare and valuable.
Sassa
K
K
First Dept. of Internal Medicine, Toyama Medical & Pharmaceutical University.
Mizushima
Y
Y
Yoshida
Y
Y
Shinoda
K
K
Kobayashi
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000150:complications / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011009:Pneumoconiosis / Q000150:complications*; D017741:Survivors; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin